Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol and Brain Metabolism in Postmenopausal Women with Diabetes
NCT03681691Phase 1Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2019
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial of estradiol topical in Dementia and Alzheimer's disease (AD) (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoints: Fluorodeoxyglucose Positron Emission Tomography Whole Brain at Week 8 and Acetoacetate Uptake Positron Emission Tomography Whole Brain at Week 8. Started May 2019; status: completed.
02
Drugs
estradiol topical
03
Conditions
DementiaAlzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03681691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03681691.